本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Nuvectis Pharma, Inc.

8.87
+0.16501.90%
盘后8.870.00000.00%16:00 EDT
成交量:12.56万
成交额:112.40万
市值:2.07亿
市盈率:-7.98
高:9.30
开:8.86
低:8.78
收:8.70
数据加载中...
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/06

重要事件披露

Form 8-K - Current report
2025/01/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/05

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

重要事件披露

Form 8-K - Current report
2024/08/29

重要事件披露

Form 8-K - Current report
2024/08/06

重要事件披露

Form 8-K - Current report
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/28

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]